Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001193125-25-294092
Filing Date
2025-11-24
Accepted
2025-11-24 21:22:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2843
  Complete submission text file 0001193125-25-294092.txt   4262
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Subject) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40407 | Film No.: 251514874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address
Carter Jason S (Reporting) CIK: 0002045094 (see all company filings)

Type: 144